Visiun’s CEO to Present Keynote Session at the CLMA Western Lake Erie Meeting

Ann Arbor, Michigan – Visiun is pleased to announce that Tom Joseph, Visiun President & CEO, will be presenting the keynote session at the CLMA Western Lake Erie Chapter Meeting. The presentation, titled ‘Test Utilization Management Using Real-Time Analytics’ will take place on Thursday, March 16, at the Quality Inn in Perrysburg, Ohio at 1:00PM.

In an environment of decreasing reimbursement, managing test utilization to reduce unnecessary testing is one of the greatest opportunities for laboratories to improve financial performance while enhancing patient care.  Joseph will provide an overview of the environment that has fueled an increased focus on test utilization and will examine the approaches health systems are using to manage both overutilization and underutilization using laboratory analytics.  An analysis of industry data will be discussed including surveys of physician practice patterns along with key benchmarks to highlight the scale of opportunities across the industry, from community hospitals to leading academic medical centers.  Attendees can expect an in-depth look into the variety of strategies health systems can follow to manage improved utilization efforts and how analytics are driving improved utilization practices in the laboratory.

If you are not attending the CLMA Western Lake Erie Meeting but would like additional information on this presentation or on Visiun’s laboratory analytics, please contact Kristina Ziaugra at or 727-420-5152.


About Visiun, Inc.

Visiun, Inc. is the leading provider of performance analytics to the laboratory industry.  Headquartered in Ann Arbor, Michigan, Visiun has been providing services to the laboratory industry for over six years, with hundreds of laboratories installed across the United States.  Performance Insight™, Visiun's core product, provides laboratory managers with a comprehensive suite of analytics that deliver immediate improvements in performance, efficiency, and quality.  For more information, please visit